Christine Aylward

Christine is the Founder of Magnetic Ventures and has worked at the forefront of healthcare innovation since the beginning of her career at Roche.
She has been in venture capital business since 2011.
As a founder, business executive and investor, Christine evaluates companies through a unique lens, making her an invaluable resource for entrepreneurs.
She has a proven track record of investing in healthcare leaders, and her meaningful relationships and expertise span pharmaceuticals, diagnostics, genomics, technology, and finance.
Her experience commercializing global franchises and building companies has awarded her deep domain and industry operating expertise.
She has helped launch more than 20 products in the pharmaceutical, genomics, healthcare technology and diagnostic sectors.
Christine began her career at Roche, where she launched the revolutionary technology polymerase chain reaction (PCR), formed the first cross collaboration between the pharmaceutical and diagnostic divisions, was a key member of several marketing teams, and was placed on the Executive Development Track.
Most recently, Christine was a Managing Director at Foresite Capital, which she joined at its founding.
There she was instrumental in building the firm to $1.2 billion in assets under management and helped identify and grow some of the most valuable companies within the portfolio.
Christine has also been an entrepreneur in the media sector and was a partner at a technology-focused investment bank acquired by Goldman Sachs.
Christine currently sits on the boards of Branch Biosciences, Relation Therapeutics, SameSky Health, Amydis, and UCSF Health Hub.